AbbVie xStock Prijs
ABBVXRang 3623
AbbVie xStock (ABBVX) Prijs Live Grafiek
De prijs van AbbVie xStock (ABBVX) is vandaag $211.59, met een 24-uurs handelsvolume van $50.14. Hierdoor heeft AbbVie xStock (ABBVX) een marktkapitalisatie van $289.77K, wat neerkomt op een marktdominantie van 0.0025%. De prijs van AbbVie xStock (ABBVX) is de afgelopen 24 uur met 0.00% veranderd.
ABBVX Prijsgegevens
- 24u Omzet$50.14
- All Time High (ATH)$266.49
- 24u hoog$211.59
- All-Time Low (ATL)$156
- 24u Laag$211.59
ABBVX Marktkapitalisatie-info
- Marktkapitalisatie$289.77K
- Volledig verwaterde waardering$68.45M
- Marktkapitalisatie/FDV0.42%
- MarktsentimentNeutraal
ABBVX Aanbod
- Circulerend aanbod1.36K ABBVX
- Totale voorraad323.51K ABBVX
- Maximale voorraad∞
*Gegevens zijn alleen ter referentie
AbbVie xStock(ABBVX) wordt voorspeld gemiddeld $211.59 te zijn in 2026, met een mogelijke schommeling tussen de laagste prijs $139.64 en de hoogste prijs $228.51. Tegen 2031 kan de prijs van AbbVie xStock(ABBVX) oplopen tot $314.14, wat een potentieel rendement van +44.00% biedt ten opzichte van de huidige AbbVie xStock-prijs.
Jaar | Minimale prijs | Hoogste prijs | Gemiddelde prijs | Verandering |
|---|---|---|---|---|
2026 | $139.64 | $228.51 | $211.59 | -- |
2027 | $160.63 | $231.05 | $220.05 | +4.00% |
2028 | $175.93 | $254.87 | $225.55 | +6.00% |
2029 | $163.34 | $261.83 | $240.21 | +13.00% |
2030 | $185.75 | $358.96 | $251.02 | +18.00% |
2031 | $247.04 | $314.14 | $304.99 | +44.00% |
De prijs van AbbVie xStock(ABBVX) is de afgelopen 24 uur met -- bewogen, en met +2.69% in de afgelopen 7 dagen. De prijs van AbbVie xStock(ABBVX) is -12.72% in de afgelopen 30 dagen, en -4.16% over het afgelopen jaar.
Tijdsperiode | Bedrag wijzigen | % Verandering |
|---|---|---|
1H | -$0.03174 | -0.015% |
24H | +$0 | -- |
7D | +$5.54 | +2.69% |
30D | -$30.83 | -12.72% |
1Y | -$9.18 | -4.16% |
Over AbbVie xStock (ABBVX)
Contract
xswbinnky...eeqssqoie
Verkenners
explorer.solana.com
Website
xstocks.com
Community
Tags
AbbVie xStock (ABBVx) is a tracker certificate issued as Solana SPL and ERC-20 tokens. ABBVx tracks the price of AbbVie company stock (the underlying). ABBVx is designed to give eligible cryptocurrency market participants regulatory-compliant access to the price of AbbVie company stock, whilst maintaining the benefits of blockchain technology.
- GateNewsMoonshot AI has released Kimi K2.6, featuring chat and Agent modes on kimi.com. It excels in coding benchmarks, supports 4,000 tool invocations, and upgraded parallel functionality for autonomous scenarios.
- GateNewsJustin Sun withdrew 55.01 million USDC from a major CEX and deposited it into the Spark protocol, totaling $179 million in deposits since Aave's bad debt incident, highlighting Spark's growing liquidity.
- GateNewsSingapore Gulf Bank has launched USDC minting and redemption services on the Solana network for institutional clients, enhancing transaction efficiency and addressing challenges in transferring large sums between traditional and crypto markets.
- GateNewsThe FCC plans to revoke wireless product testing credentials for Chinese labs, with implementation by the end of April and a two-year transition. HuaCe Testing expects limited impact on its revenue from this change.
- GateNewsThe SEC and CFTC propose to reduce hedge fund reporting requirements by exempting smaller advisors and increasing the asset threshold for Form PF from $150 million to $1 billion, with data used confidentially for oversight.
- GateNewsPharos has detailed the public sale for its PROS token, aiming to raise $1 million by offering 0.1% of total supply at $1.00 per token. Participants must complete KYC/KYB verification and can choose between lockup options. Registration began on April 20.